Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-25-002184
Filing Date
2025-01-14
Accepted
2025-01-14 17:00:06
Documents
2
Period of Report
2025-01-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1586
2 ex24-1.htm EX-24.1 13964
  Complete submission text file 0001493152-25-002184.txt   17291
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Issuer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141
Business Address
Ratner Elena (Reporting) CIK: 0002049829 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-11460 | Film No.: 25530043